Front Cover: The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders (ChemMedChem 13/2019)
ChemMedChem - United Kingdom
doi 10.1002/cmdc.201900365
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 3, 2019
Authors
Publisher
Wiley